A.B. in biology summa cum laude from Princeton and his M.D. from Harvard Medical School. He completed clinical training in internal medicine and neurology at the Massachusetts General Hospital and finished a postdoctoral fellowship in genetics at Harvard.

Wylie Burke, M.D., Ph.D., is professor and chair of the Department of Bioethics and Humanities at the University of Washington. She received a Ph.D. in genetics and an M.D. from the University of Washington and completed a residency in internal medicine at the University of Washington. She was a medical genetics fellow at the University of Washington from 1981 to 1982. Dr. Burke was a member of the Department of Medicine at the University of Washington from 1983 to 2000, where she served as associate director of the internal medicine residency program and founding director of the University of Washington’s Women’s Health Care Center. She was appointed chair of the Department of Medical History (now the Department of Bioethics and Humanities) in October 2000. She is also an adjunct professor of medicine and epidemiology and a member of the Fred Hutchinson Cancer Research Center. She is a member of the Institute of Medicine and the Association of American Physicians and is a past president of the American Society of Human Genetics. Dr. Burke’s research addresses the social, ethical, and policy implications of genetics, including responsible conduct of genetic and genomic research, genetic test evaluation, and implications of genomic health care for underserved populations. She is director of the University of Washington Center for Genomics and Healthcare Equality, a National Human Genome Research Institute center of excellence in ethical, legal, and social implications research, and co-director of the Northwest-Alaska Pharmacogenomic Research Network.

Walter Capone, M.B.A., is the chief operating officer of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC). He oversees the core business operations of the MMRF and as part of the executive committee executes the growth initiatives outlined in the organization’s strategic plan. He has 20 years of pharmaceutical and biotechnology leadership experience in the areas of commercial development, operations, finance, marketing, and sales in the United States and internationally. Prior to joining the MMRF, he was the vice president of commercial development and operations at Progenics Pharmaceuticals. He previously worked at a number of entrepreneurial pharmaceutical and biotechnology ventures throughout the United States and Europe including Trimeris, Triangle Pharmaceuticals, and Cyanamid Benelux. He started his career at leading global pharmaceutical companies including Lederle, Wyeth, and Bristol-Myers Squibb. He received his B.A. in international relations



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement